| Muhammad K Shakeel, MD | |
|
779 Senate Pkwy, Anderson, SC 29621-1820 | |
| (864) 224-8716 | |
| (864) 226-2287 |
| Full Name | Muhammad K Shakeel |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 36 Years |
| Location | 779 Senate Pkwy, Anderson, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477558740 | NPI | - | NPPES |
| 00560568F | Other | GA | MEDICAID |
| T44789 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 20436 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fresenius Medical Care North Anderson | Anderson, SC | Dialysis facility |
| Anmed Health | Anderson, SC | Hospital |
| Ty Cobb Regional Medical Center, Llc | Lavonia, GA | Hospital |
| Cannon Memorial Hospital | Pickens, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology And Internal Medicine Of Anderson Pa | 4688777857 | 6 |
News Archive
Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).
A comprehensive drug development strategy that starts with extensive screening of potential targeting agents and then narrows down to a small-molecule prototype has yielded two potential drugs that block cancer-promoting pathways in novel ways, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in two papers published back-to-back online at the Proceedings of the National Academies of Science.
Today CHEP lauded the U.S. Senate for the passage of S. 510, The Food and Drug Administration (FDA) Food Safety Modernization Act of 2010. The bill will now be sent to the U.S. House for review and approval, before being signed into law.
A group of researchers from the United States discovered that the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the formation of highly inflammatory blood clots amenable to neutralization by a fibrin-targeting monoclonal antibody – opening the door for a completely new strategy to reduce thrombotic inflammation in coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710918321 PECOS PAC ID: 1951215243 Enrollment ID: O20031119000738 |
News Archive
Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).
A comprehensive drug development strategy that starts with extensive screening of potential targeting agents and then narrows down to a small-molecule prototype has yielded two potential drugs that block cancer-promoting pathways in novel ways, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in two papers published back-to-back online at the Proceedings of the National Academies of Science.
Today CHEP lauded the U.S. Senate for the passage of S. 510, The Food and Drug Administration (FDA) Food Safety Modernization Act of 2010. The bill will now be sent to the U.S. House for review and approval, before being signed into law.
A group of researchers from the United States discovered that the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the formation of highly inflammatory blood clots amenable to neutralization by a fibrin-targeting monoclonal antibody – opening the door for a completely new strategy to reduce thrombotic inflammation in coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Entity Name | Nephrology & Internal Medicine Of Anderson Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043275456 PECOS PAC ID: 4688777857 Enrollment ID: O20070307000668 |
News Archive
Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).
A comprehensive drug development strategy that starts with extensive screening of potential targeting agents and then narrows down to a small-molecule prototype has yielded two potential drugs that block cancer-promoting pathways in novel ways, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in two papers published back-to-back online at the Proceedings of the National Academies of Science.
Today CHEP lauded the U.S. Senate for the passage of S. 510, The Food and Drug Administration (FDA) Food Safety Modernization Act of 2010. The bill will now be sent to the U.S. House for review and approval, before being signed into law.
A group of researchers from the United States discovered that the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the formation of highly inflammatory blood clots amenable to neutralization by a fibrin-targeting monoclonal antibody – opening the door for a completely new strategy to reduce thrombotic inflammation in coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Muhammad K Shakeel, MD 779 Senate Pkwy, Anderson, SC 29621-1820 Ph: (864) 224-8716 | Muhammad K Shakeel, MD 779 Senate Pkwy, Anderson, SC 29621-1820 Ph: (864) 224-8716 |
News Archive
Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).
A comprehensive drug development strategy that starts with extensive screening of potential targeting agents and then narrows down to a small-molecule prototype has yielded two potential drugs that block cancer-promoting pathways in novel ways, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in two papers published back-to-back online at the Proceedings of the National Academies of Science.
Today CHEP lauded the U.S. Senate for the passage of S. 510, The Food and Drug Administration (FDA) Food Safety Modernization Act of 2010. The bill will now be sent to the U.S. House for review and approval, before being signed into law.
A group of researchers from the United States discovered that the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the formation of highly inflammatory blood clots amenable to neutralization by a fibrin-targeting monoclonal antibody – opening the door for a completely new strategy to reduce thrombotic inflammation in coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
Shahzad H Sheikh, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 118 Montgomery Dr, Anderson, SC 29621 Phone: 864-512-5849 Fax: 864-512-7575 | |
Winston Cordell Floyd, MD Nephrology Medicare: Medicare Enrolled Practice Location: 400 North Fant Street, Suite G, Anderson, SC 29621 Phone: 864-224-2197 Fax: 864-225-0033 | |
David W Potts, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 118 Montgomery Dr, Anderson, SC 29621 Phone: 864-512-3915 Fax: 864-260-3920 | |
Sanjeev Kumar, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 819 N Fant St, Anderson, SC 29621 Phone: 864-261-1800 Fax: 864-261-1856 | |
Rajeev Malik, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2000 E Greenville St, Ste 5000, Anderson, SC 29621 Phone: 864-224-5765 Fax: 864-224-1449 | |
Daniel W. Grisham Sr., M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St Ste 2300, Anderson, SC 29621 Phone: 864-512-5780 Fax: 864-375-1155 | |
Dr. William Muirhead Turner, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 131 Addis Cir, Anderson, SC 29626 Phone: 864-934-6833 |